1887

Abstract

SUMMARY: Capsules of only begin to be formed towards the end of exponential growth and appear first at the extremities of the cells. Once begun, capsule formation is not inhibited by tetracycline, so that capsular polypeptide is not synthesized like protein. Cultures were grown in broth + albumin in the presence of 0.015 M-HCO—and 5 vol. CO + 95 vol. air until capsulation began, and were then incubated in air in tetracycline broth (to inhibit subsequent enzyme formation): capsules continued to increase in size, which suggested that HCO—made capsular synthesis possible but was not required for the formation of the polypeptide itself. Cultures transferred from air to adequate concentrations of CO did not immediately become capsulated, whatever their stage of growth.

Mutants with altered nutritional requirements for capsulation were selected by phage α from wild-type strains grown either (1) on charcoal agar in air, so selecting for CO-independence (D mutants), or (2) on bicarbonate agar incubated in CO. so selecting for independence of an absorbent (F mutants). Both classes formed capsules in air (≃ 0.0001 M-HCO-) and the capsular polymer apparently had the same chemical structure as that of their parent. No evidence was found that the mutants differed from their parent in being able to fix HCO—more efficiently or in being able to utilize compounds normally derived from HCO—that were present in the medium. They may therefore arise following mutation in regulatory genes controlling capsular synthesis.

Some D mutants grew very slowly in CO but yielded CO-resistant mutants of which 66 were examined: 44 resembled the parental strain 2160s, and 22 were rough (C—). CO-sensitive D mutants also gave rise to derivatives which formed rough colonies in air: some resembled strain 2160s; others were C—; but some had a new phenotype in being rough in air, fully capsulated in 0.006-0-015 M-HCO—and inhibited by 0.03 M-HCO -.

Absorbents are required by wild-type strains to inactivate the long-chain fatty acids that occur in nutrient media. These acids are thought to interfere with the uptake or utilization of HCO—, rather than with a later stage in capsular synthesis, because (1) they do not inhibit capsulation of D or F mutants, (2) they enable CO-sensitive D mutants to grow in CO, and (3) they probably interfere with toxin formation, which also requires CO As toxin is protein it must be synthesized differently from capsular polypeptide, and the only stage common to both pathways is therefore likely to be HCO—uptake.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-43-1-119
1966-04-01
2019-10-21
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-43-1-119
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error